Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts.
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Acute osteoporosis after spinal cord injury is related to an early increase in osteoclastic resorption. Healthy subjects subjected to bed rest similarly increase their osteoclast number in trabecular bone. Bisphosphonates possess a highly antiosteoclastic activity. The effects of a 120 day bed rest period, with or without etidronate therapy on cortical bone were measured in 15 subjects. Cortical thickness and cortical porosity were measured on transiliac bone biopsies taken before and after the bed rest period. Osteoclasts were detected histo-chemically and were counted with a semiautomatic image analyzer. Cortical thickness, cortical porosity, and cortical osteoclast number were not significantly modified in subjects submitted to bed rest alone. In the etidronate-treated patients, cortical bone mass parameters were also found to be unaffected, but the most striking feature was that the osteoclast number was unchanged. Trabecular osteoclasts, on the contrary, were increased in the untreated subjects (+95.2%) but decreased in the treated subjects (-78%). Bone cells may have heterogeneous responses according to their trabecular or cortical location. Cortical osteoclasts seem to be unaffected by etidronate therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Biochemical markers of bone resorption and osteoclast numbers are significantly elevated in spaceflight and bed rest (275, 276)”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [276]
In the citing paper
“bisphosphonate treatment suppressed osteoclast numbers in cancellous bone but not in cortical bone (276).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [276]
Citations
Cites
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Riggs, B. L., & Melton, L. J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606263142605 · Cited by 1,915
The Mechanical Adaptations of Bones
Currey, J. D. (1984) · Princeton University Press eBooks · doi:10.1515/9781400853724 · Cited by 896
Evidence for the Secretion of an Osteoclast Stimulating Factor in Myeloma
Mundy, G. R., Raisz, L. G., Cooper, R. A., Schechter, G. P., & Salmon, S. E. (1974) · New England Journal of Medicine · doi:10.1056/nejm197411142912001 · Cited by 671
Quantitative histological data on disuse osteoporosis: Comparison with biological data
Minaire, P., Meunier, P., Edouard, C., Bernard, J., Courpron, P., & Bourret, J. (1974) · Calcified Tissue Research · doi:10.1007/bf02547214 · Cited by 435
Self-citationWolff’s Law of Trabecular Architecture at Remodeling Equilibrium
Cowin, S. C. (1986) · Journal of Biomechanical Engineering · doi:10.1115/1.3138584 · Cited by 425
Calcium Homeostasis in Immobilization: An Example of Resorptive Hypercalciuria
Stewart, A. F., Adler, M., Byers, C. M., Segre, G. V., & Broadus, A. E. (1982) · New England Journal of Medicine · doi:10.1056/nejm198205133061903 · Cited by 385
Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.
Boonekamp, P. M., van der Wee-Pals, L. J. A., LENNEP, M. V., Cw, T., & Bijvoet, O. L. (1986) · PubMed · Cited by 345
Russell, R. G. G., Mühlbauer, R. C., Bisaz, S., Williams, D. A., & Fleisch, H. (1970) · Calcified Tissue Research · doi:10.1007/bf02196199 · Cited by 341
Osteoporosis: Etiology, Diagnosis, and Management
Kleerekoper, M. (1988) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62374-x · Cited by 332
Research works printed but not linked: 7
- Bang, 1978, Fluoride and Bone, 168
- Vico, 1987, Etude histologique de la masse et des activités cellulaires osseuses après un décubitus de 120 jours. Essai de protocoles préventifs, Ann Biol Clin (Paris), 45, 145
- Lellouche, 1974, Méthodes statistiques en expérimentation biologique, 131
- Jaworski, 1980, Study of cell kinetics within evolving secondary Haversien system, J Anat, 131, 91
- Hattner, 1963, Mean skeletal age: Its meaning and a method of calculation, Henry Ford Hosp Med Bull, 11, 201
- Reginster, 1987, Bone Mineral Measurements by Photon Absorptiometry: Methodological Problems, 72
- Brookes, 1974, La circulation osseuse
Cited by
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Long-duration bed rest as an analog to microgravity
Hargens, A. R., & Vico, L. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00935.2015 · Cited by 360
Self-citationDissociated hip and spine demineralization: a specific finding in spinal cord injury.
Leslie, W. D., & Nance, P. W. (1993) · PubMed · Cited by 104
TREATMENT OF OSTEOPOROSIS WITH BISPHOSPHONATES
Watts, N. B. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70014-1 · Cited by 103
Effects of tiludronate on bone loss in paraplegic patients
Dr. Chappard, D., Minaire, P., Privat, C., Berard, E., Mendoza-Sarmiento, J., Tournebise, H., Basle, M., Audran, M., Rebel, A., Picot, C., et al. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100116 · Cited by 97
Self-citationAdvances in the understanding of myeloma bone disease and tumour growth
Yaccoby, S. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08141.x · Cited by 95
Mashiba, T., Turner, C. H., Hirano, T., Forwood, M. R., Jacob, D., Johnston, C. C., & Burr, D. B. (2001) · Bone · doi:10.1016/s8756-3282(01)00575-0 · Cited by 94
Rico, H., Revilla, M., Hernández, E. R., Villa, L. F., & de Buergo, M. A. (1995) · Calcified Tissue International · doi:10.1007/bf00298606 · Cited by 93
Escribano, A., Revilla, M., Hernández, E. R., Seco, C., González-Riola, J., Villa, L. F., & Rico, H. (1997) · Calcified Tissue International · doi:10.1007/s002239900214 · Cited by 83
Treatment of Osteoporosis with Bisphosphonates
Watts, N. B. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70194-0 · Cited by 81
Bikle, D. D., Morey-Holton, E. R., Doty, S. B., Currier, P. A., Tanner, S. J., & Halloran, B. P. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091115 · Cited by 72
Ongphiphadhanakul, B., Alex, S., Braverman, L. E., & Baran, D. T. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650071015 · Cited by 70
Bauman, W. A., Cirnigliaro, C. M., Fountaine, M. F. L., Martinez, L., Kirshblum, S., & Spungen, A. M. (2014) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-014-0602-x · Cited by 67
Ovulatory premenopausal women lose cancellous spinal bone: A five year prospective study
Prior, J. C., Vigna, Y. M., Barr, S. I., Kennedy, S., Schulzer, M., & Li, D. K. B. (1996) · Bone · doi:10.1016/8756-3282(95)00487-4 · Cited by 59
Clodronate increases the calcium content in fracture callus: An experimental study in rats
Nyman, M. T., Paavolainen, P., & Lindholm, T. S. (1993) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/bf00451880 · Cited by 48
Libouban, H., Moreau, M.-F., Baslé, M. F., Bataille, R., & Chappard, D. (2003) · Bone · doi:10.1016/s8756-3282(03)00196-0 · Cited by 48
Self-citationHeilberg, I. P., Martini, L. A., Teixeira, S. H., Szejnfeld, V. L., Carvalho, A. B., Lobão, R. R. D. S., & Draibe, S. A. (1998) · The Nephron journals/Nephron journals · doi:10.1159/000045089 · Cited by 44
Journal of Bone and Mineral Research
Ott, S. M. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650081329 · Cited by 42
Continuous and cyclical clodronate therapies and bone density in postmenopausal bone loss
Giannini, S., D’Angelo, A., Sartori, L., Passeri, G., Carbonare, L. D., & Crepaldi, G. (1996) · Obstetrics and Gynecology · doi:10.1016/0029-7844(96)00171-8 · Cited by 40
The Therapy of Osteoporosis and the Importance of Cortical Bone
Rico, H. (1997) · Calcified Tissue International · doi:10.1007/s002239900361 · Cited by 40
Differential turnover of cortical and trabecular bone in transgenic mice overexpressing cathepsin K
Morko, J. P., Kiviranta, R., Hurme, S. A. M., Rantakokko, J., & VUORIO, E. I. (2005) · Bone · doi:10.1016/j.bone.2005.02.006 · Cited by 39
Effect of etidronate on bone in orchidectomized and sciatic neurectomized adult rats
Iwamoto, J., Takeda, T., Katsumata, T., Tanaka, T., Ichimura, S., & Toyama, Y. (2002) · Bone · doi:10.1016/s8756-3282(01)00687-1 · Cited by 38
Yoshida, Y., Moriya, A., Kitamura, K., Inazu, M., Okimoto, N., Okazaki, Y., & Nakamura, T. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.6.1011 · Cited by 37
STEROID–INDUCED OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Cunnane, G., & Lane, N. E. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70140-x · Cited by 36
Osteoporosis in Women with Spinal Cord Injuries
Ott, S. M. (2001) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/s1047-9651(18)30086-x · Cited by 35
Osteoclasts in RA: Diverse origins and functions
Goff, B. L., Berthelot, J., Maugars, Y., & Heymann, D. (2013) · Joint Bone Spine · doi:10.1016/j.jbspin.2013.04.002 · Cited by 34
Healing of a tibial double osteotomy is modified by clodronate administration: An experimental study
Nyman, M. T., Gao, T., Lindholm, T. C., & Lindholm, T. S. (1996) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/bf00573453 · Cited by 32
Libouban, H., Blouin, S., Moreau, M.-F., Baslé, M. F., Audran, M., & Chappard, D. (2007) · Micron · doi:10.1016/j.micron.2007.09.006 · Cited by 30
Self-citationThe effect of zoledronate on bone remodeling during the healing process
Matos, M. A., Araújo, F. P., & Paixão, F. B. (2007) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-86502007000200007 · Cited by 29
Hyvönen, P. M., Karhi, T., Kosma, V., Liimola‐Luoma, L., & Hanhijärvi, H. (1994) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1994.tb00379.x · Cited by 28
The effect of pamidronate in a new model of immobilization in the dog
Grynpas, M. D., Kasra, M., Renlund, R., & Pritzker, K. P. H. (1995) · Bone · doi:10.1016/8756-3282(95)00296-p · Cited by 25
TREATMENT OF OSTEOPOROSIS WITH BISPHOSPHONATES
Watts, N. B. (1994) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00357-4 · Cited by 25
Mochizuki, S.-I., Fujise, N., Higashio, K., & Tsuda, E. (2002) · Journal of Bone and Mineral Metabolism · doi:10.1007/s774-002-8441-x · Cited by 24
“Similar findings that bisphosphonate exerts more potent pharmacological effect at the same sites were reported in bisphosphonate-treated acute osteoporosis after spinal cord injury [23].”
ResultWang, Z., Han, Z., Tao, J., Lü, P., Liu, X., Wang, J., Wu, B., Huang, Z., Yin, C., Tan, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108106 · Cited by 23
Orme, S. M., Simpson, M., Stewart, S. P., Oldroyd, B., Westmacott, C. F., Smith, M. A., & Belchetz, P. E. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02537.x · Cited by 23
The cathepsin K inhibitor AAE581 induces morphological changes in osteoclasts of treated patients
Chappard, D., Libouban, H., Mindeholm, L., Baslé, M. F., Legrand, É., & Audran, M. (2010) · Microscopy Research and Technique · doi:10.1002/jemt.20813 · Cited by 21
Self-citationIwamoto, J., Seki, A., Takeda, T., Satō, Y., & Yamada, H. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-005-0628-1 · Cited by 19
Influence of body parameters on female peak bone mass and bone loss
Ortolani, S., Trevisan, C. L., Bianchi, M. L., Gandolini, G., Cherubini, R., & Polli, E. E. (1993) · Osteoporosis International · doi:10.1007/bf01621866 · Cited by 16
Sensitivity of the HEp-2000 Substrate for the Detection of Anti-SSA/Ro60 Antibodies
Peene, I., Ael, W. V., Vandenbossche, M., Vervaet, T., Veys, E. M., & Keyser, F. D. (2000) · Clinical Rheumatology · doi:10.1007/s100670050010 · Cited by 15
Bauman, W. A., & Cardozo, C. P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00047-9 · Cited by 14
Søballé, K., Chen, X., Jensen, T. B., Kidder, L., & Bechtold, J. E. (2007) · Acta Orthopaedica · doi:10.1080/17453670710014581 · Cited by 12
Recovery from pamidronate (APD): A two-year study in the dog
Grynpas, M. D., Kasra, M., Dumitriu, M., Nespeca, R., Very, J. M., & Mertz, B. P. (1994) · Calcified Tissue International · doi:10.1007/bf00310408 · Cited by 12
Osteoclasts: Crucial in Rheumatoid Arthritis
Jeong, W.-J., & Kim, H.-J. (2016) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2016.23.3.141 · Cited by 10
Gender-specific increase of bone mass by CART peptide treatment is ovary-dependent
Gerrits, H., Bakker, N. E. C., Laat, C. J. V. D. V., Bourgondiën, F. G. M., Peddemors, C., Litjens, R. H. G. M., Kok, H. J., Vogel, G. M. T., Krajnc-Franken, M. A. M., & Gossen, J. A. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.500 · Cited by 8
Spinal Cord Injury: Skeletal Pathophysiology and Clinical Issues
Bauman, W. A., & Cardozo, C. P. (2013) · Wiley eBooks · doi:10.1002/9781118453926.ch122 · Cited by 6
Vernikos-Danellis, J. (1995) · Acta Astronautica · doi:10.1016/0094-5765(95)98733-p · Cited by 6
Cardozo, C. P., & Bauman, W. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00040-x · Cited by 6
Iwamoto, J., Seki, A., Takeda, T., Satō, Y., Yamada, H., & Yeh, J. K. (2018) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.55.333.r1 · Cited by 6
Kün‐Darbois, J., Quenel, L., Badja, S., & Chappard, D. (2017) · Acta Haematologica · doi:10.1159/000481425 · Cited by 6
Self-citationAoki, K. (1992) · Japanese Journal of Oral Biology · doi:10.2330/joralbiosci1965.34.595 · Cited by 6
N’Diaye, M., Libouban, H., Aguado, E., Bouvard, B., Audran, M., & Chappard, D. (2014) · Micron · doi:10.1016/j.micron.2014.10.001 · Cited by 4
Self-citationChlebek, C., Raynor, M. S., Ross, F. P., & van der Meulen, M. C. H. (2025) · JBMR Plus · doi:10.1093/jbmrpl/ziaf105 · Cited by 4
Estrogen status and bone mass in the premenopausal period: Is osteoporosis a developmental disease?
Civitelli, R., Villareal, D. T., & Armamento‐Villareal, R. (1993) · Journal of Endocrinological Investigation · doi:10.1007/bf03348937 · Cited by 4
Importance of raising awareness about spontaneous insufficiency fractures in the bedridden elderly
Fujiwara, S. (2010) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.10.38 · Cited by 3
Flatt, C. L., Fick, A., James, B., Hester, F., Nano, S., Steinke, A. M., Li, J., Niebur, G. L., & Littlepage, L. E. (2026) · Calcified Tissue International · doi:10.1007/s00223-025-01470-x · Cited by 2
Estudio predictivo de la osteoporosis
Mezcua, J. R. R. (1996) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Ostéoclastes dans la PR : hétérogénéité de leurs origines et fonctions
Goff, B. L., Berthelot, J., Maugars, Y., & Heymann, D. (2013) · Revue du Rhumatisme · doi:10.1016/j.rhum.2013.02.021
La paradójica acción, a nivel óseo, de los bisfosfonatos
Lenza, H. R. (2003) · Revista Clínica Española · doi:10.1016/s0014-2565(03)71206-5
Iwamoto, J., Takeda, T., Satō, Y., & Uzawa, M. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05787-4
Koltsov, J. C. B. (2013) · eCommons (Cornell University)
Metadata
- Authors
- Chappard, D., Petitjean, M., Alexandre, C., Vico, L., Minaire, P., & Riffat, G.
- Affiliations
- LBTO—Laboratoire de Biologie du Tissu Osseux, GIP “Exercise,” Faculté de Médecine, Saint Etienne, France
- Service de Rédaptation Fonctionnelle, Saint Etienne, France
- Corresponding author
- Chappard, Daniel
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1991-07-01
- Volume
- 6
- Issue
- 7
- Pages
- 673-680
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1984269259
- Cited by
- 65
- References
- 53
- Citations by year
- 2026: 1 · 2025: 1 · 2020: 1 · 2018: 1 · 2017: 1 · 2016: 2 · 2014: 3 · 2013: 4
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Space Studies
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- etidronate, bisphosphonates, osteoclasts, cortical bone, trabecular bone, bone resorption, bed rest, osteoporosis, spinal cord injury, cortical thickness, cortical porosity, osteoclast number
- MeSH terms
- Adult, Bed Rest, Bone and Bones, Bone Resorption, Cell Count, Humans, Male, Osteoclasts, Etidronic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.